Multiple Myeloma Coverage from Every Angle

Sarah A. Holstein, MD, PhD, on Multiple Myeloma: New Induction Therapies

Posted: Wednesday, August 1, 2018

Sarah A. Holstein, MD, PhD, of the University of Nebraska Medical Center, discusses the current standard of treatment for multiple myeloma, the benefit of upfront transplant, and ongoing studies that will better define the value of adding monoclonal antibody therapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.